• FDA expands Trodelvy approval for breast cancer

    1 month ago - By Healio

    The FDA expanded the approval of sacituzumab govitecan-hziy to include treatment of certain patients with hormone receptor-positive disease.
    Sacituzumab govitecan-hziy is a Trop-2-directed antibody-drug conjugate.
    The FDA previously approved the agent for treatment of certain patients with metastatic triple-negative breast cancer or metastatic urothelial cancer.
    The new indication applies to use of sacituzumab govitecan-hziy to treat patients with unresectable locally advanced or metastatic hormone receptor-positive, HER2-negative breast cancer who received
    Read more ...

     

  • Faking a Cancer Dx? Fallopian Tube Removal; Trodelvy's New Breast Cancer Indication

    Faking a Cancer Dx? Fallopian Tube Removal; Trodelvy's New Breast Cancer Indication

    1 month ago - By MedPageToday

    A 19-year-old Iowa woman has been arrested after being accused of faking diagnoses of leukemia and pancreatic cancer in order to collect more than $37,000 in online donations.
    The Ovarian Cancer Research Alliance...
    Read more ...